Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingObservational

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology: A Promising Solution (PROMIS AYA) - Aim 2

NCT ID: NCT06897137Sponsor: Wake Forest University Health SciencesLast updated: 2026-05-07

Summary

This study evaluates how adolescent and young adults with cancer in the U.S. and their loved ones respond to questions that will later be used with people who may have cancer and other chronic health conditions

Detailed description

PRIMARY OBJECTIVES: * To refine patient-reported outcome assessment tools of body image, fertility, and financial burden for PROMIS and evaluate assumptions for IRT consistent with PROMIS Scientific Standards (e.g., unidimensionality, local independence). * To examine item-level properties to support computer adaptive testing and evaluate possible differential item functioning (DIF). Secondary Objective * To create short forms and examine convergent validity of the new body image, fertility, and financial burden short forms and item banks with corresponding legacy measures of those constructs. OUTLINE: This is an observational study. Participants complete surveys on study.

Arms & interventions

  • OtherSurveys/Questionnaires

    Participants will complete self-report questionnaires via Redcap. The questionnaires should take less than 30 minutes and will include the following options based on their relevance to each sample: 1) sociodemographic (including the comorbidity index) and clinical information, 2) newly developed item pools for body image, fertility, and financial burden, 3) legacy measures for body image, fertility, and financial burden, 4) the PROMIS AYA Health Status Profile, and 5) the PROMIS Global.

Outcome measures

Primary

  • Refining of Item Pools - Development of Four Item Banks

    Upon completion of data analysis and study team review, investigators will have four unidimensional and locally independent, calibrated item banks: three for AYAs (body image, fertility, and financial burden) and one for caregivers (financial burden). In order to successfully calibrate an item bank, an n=500 is required per bank. In order to examine differential item functioning (DIF), a minimum n=200 per group is recommended. Our proposed sample sizes and specific subgroup accrual targets will be needed to calibrate multiple new item banks (body image, fertility, financial burden), evaluate DIF for various categories (age, gender, race, education) within our sample subgroups (AYAs with and without cancer), and to conduct confirmatory factor analysis (CFAs) on the item banks. In addition, the AYA sample the general population will serve as our reference to establish the mean and standard deviation for body image and fertility.

    Time frame: Up to study completion, up to approximately 2 years

Secondary

  • Short Form Development Based on Item Bank Data

    Time frame: Up to study completion, up to approximately 2 years

Eligibility criteria

Sex: AllAge: 15 Years and olderHealthy volunteers: Yes
AYAs with a cancer history (AYA-C) Inclusion Criteria: * Young adults between the ages of 15 to 39 years; * First diagnosed with cancer during 15 to 39 years of age; * Able to read and understand English; * Live in the United States; * Have a new cancer diagnosis and are receiving curative treatment OR are currently 0 to 10 years post-treatment. Exclusion Criteria: * Diagnosed with basal cell skin cancer; or * Are currently receiving hospice care. AYAs General Population (AYA-GP) Inclusion Criteria: * Young adults between the ages of 15 to 39 years; * Able to read and understand English; and * Live in the United States. Caregivers of AYAs with cancer (AYA-Cg) Inclusion Criteria: * 18 years of age or older; * Able to read and understand English; * Live in the United States; * Have a child/ward/partner for whom they have provided care, AND * Their child/ward/partner is 15 to 25 years of age and meets the other eligibility criteria as an AYA participant with a cancer history (described above).

Study locations (1)

Wake Forest Baptist Comprehensive Cancer Center

Winston-Salem, North Carolina, 27157

Recruiting
Stephanie Bunch · Contact
John M Salsman, PhD · Principal Investigator